{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:41:30Z","timestamp":1767706890479,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.coph.2018.09.001","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T13:38:07Z","timestamp":1537277887000},"page":"99-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Refractory GERD, beyond proton pump inhibitors"],"prefix":"10.1016","volume":"43","author":[{"given":"Sabine","family":"Roman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Mion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2018.09.001_bib0005","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1365-2036.2010.04406.x","article-title":"Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies","volume":"32","author":"El-Serag","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2018.09.001_bib0010","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/gutjnl-2011-301897","article-title":"Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors","volume":"61","author":"Sifrim","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.coph.2018.09.001_sbref0015","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41395-018-0045-4","article-title":"Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel","volume":"113","author":"Yadlapati","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2018.09.001_bib0020","first-page":"1","article-title":"Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations","author":"Savarino","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.coph.2018.09.001_bib0025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/apt.13461","article-title":"Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis","volume":"43","author":"Ashida","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2018.09.001_bib0030","first-page":"148","article-title":"Efficacy of vonoprazan for 24-week maintenance therapy of patients with healed reflux esophagitis refractory to proton pump inhibitors","volume":"8","author":"Mizuno","year":"2018","journal-title":"Biomed Rep"},{"key":"10.1016\/j.coph.2018.09.001_bib0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000475658","article-title":"Factors associated with potassium-competitive acid blocker non-response in patients with proton pump inhibitor-refractory gastroesophageal reflux disease","volume":"95","author":"Okuyama","year":"2017","journal-title":"Digestion"},{"key":"10.1016\/j.coph.2018.09.001_bib0040","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/dote.12443","article-title":"Effect of baclofen on gastric acid pocket in subjects with gastroesophageal reflux disease symptoms","volume":"29","author":"Scarpellini","year":"2016","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.coph.2018.09.001_bib0045","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1136\/gutjnl-2012-302737","article-title":"Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial","volume":"62","author":"Shaheen","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.coph.2018.09.001_bib0050","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1365-2036.2011.04596.x","article-title":"Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease","volume":"33","author":"Zerbib","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2018.09.001_bib0055","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13058","article-title":"The selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux disease","volume":"29","author":"Rouzade-Dominguez","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2018.09.001_bib0060","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jgh.13970","article-title":"Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor","volume":"33","author":"Takeuchi","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2018.09.001_sbref0065","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/nmo.12359","article-title":"Prucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjects","volume":"26","author":"Kessing","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2018.09.001_bib0070","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/jgh.13986","article-title":"Influence of prucalopride on esophageal secondary peristalsis in reflux patients with ineffective motility","volume":"33","author":"Lei","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2018.09.001_bib0075","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/apt.14064","article-title":"Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms","volume":"45","author":"Coyle","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2018.09.001_bib0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3164\/jcbn.16-77","article-title":"Effects of rikkunshito on quality of life in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy","volume":"60","author":"Kawai","year":"2017","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.coph.2018.09.001_bib0085","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/ajg.2011.179","article-title":"Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study","volume":"107","author":"Viazis","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2018.09.001_bib0090","article-title":"A VA cooperative, randomized trial of medical and surgical treatments for patients with heartburn that is refractory to proton pump inhibitors","volume":"154","author":"Spechler","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2018.09.001_bib0095","article-title":"Efficacy of transoral incisionless fundoplication for refractory gastroesophageal reflux disease: a systematic review and meta-analysis","author":"McCarty","year":"2018","journal-title":"Endoscopy"},{"key":"10.1016\/j.coph.2018.09.001_bib0100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1553350618755214","article-title":"The TEMPO trial at 5 years: transoral fundoplication (TIF 2.0) is safe, durable, and cost-effective","volume":"25","author":"Trad","year":"2018","journal-title":"Surg Innov"},{"key":"10.1016\/j.coph.2018.09.001_bib0105","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1007\/s00464-016-5370-3","article-title":"LINX\u00ae magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: a systematic review and meta-analysis","volume":"31","author":"Skubleny","year":"2017","journal-title":"Surg Endosc"},{"key":"10.1016\/j.coph.2018.09.001_bib0110","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s11605-015-2887-z","article-title":"Gastroesophageal reflux management with the LINX\u00ae system for gastroesophageal reflux disease following laparoscopic sleeve gastrectomy","volume":"19","author":"Desart","year":"2015","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.coph.2018.09.001_bib0115","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1007\/s00464-015-4539-5","article-title":"Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: long-term 3-year results","volume":"30","author":"Rodriguez","year":"2016","journal-title":"Surg Endosc"},{"key":"10.1016\/j.coph.2018.09.001_bib0120","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/apt.13306","article-title":"Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease \u2014 interim results of an international multicentre trial","volume":"42","author":"Kappelle","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2018.09.001_bib0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4292\/wjgpt.v7.i1.145","article-title":"Effect of electrical stimulation of the lower esophageal sphincter in gastroesophageal reflux disease patients refractory to proton pump inhibitors","volume":"7","author":"Soffer","year":"2016","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"10.1016\/j.coph.2018.09.001_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.soard.2018.02.006","article-title":"Electrical stimulation of the lower esophageal sphincter to address gastroesophageal reflux disease after sleeve gastrectomy","author":"Borbely","year":"2018","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.coph.2018.09.001_bib0135","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1007\/s00464-017-5431-2","article-title":"Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease","volume":"31","author":"Fass","year":"2017","journal-title":"Surg Endosc"},{"key":"10.1016\/j.coph.2018.09.001_bib0140","doi-asserted-by":"crossref","first-page":"E443","DOI":"10.1055\/s-0044-101453","article-title":"Initial experience with a novel resection and plication (RAP) method for acid reflux: a pilot study","volume":"6","author":"Benias","year":"2018","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.coph.2018.09.001_bib0145","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/dote.12219","article-title":"Role of a health psychologist in the management of functional esophageal complaints","volume":"28","author":"Riehl","year":"2015","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.coph.2018.09.001_bib0150","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/ped.12779","article-title":"Food allergy in children with refractory gastroesophageal reflux disease","volume":"58","author":"Yukselen","year":"2016","journal-title":"Pediatr Int"},{"key":"10.1016\/j.coph.2018.09.001_bib0155","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/gut.2004.043265","article-title":"Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux","volume":"53","author":"Nilsson","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.coph.2018.09.001_bib0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/gut.2004.040337","article-title":"Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers","volume":"54","author":"El-Serag","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.coph.2018.09.001_bib0165","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3748\/wjg.v24.i21.2291","article-title":"Fiber-enriched diet helps to control symptoms and improves esophageal motility in patients with non-erosive gastroesophageal reflux disease","volume":"24","author":"Morozov","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coph.2018.09.001_bib0170","article-title":"Rumination syndrome: pathophysiology, diagnosis, and treatment","volume":"29","author":"Absah","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2018.09.001_sbref0175","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cgh.2017.10.038","article-title":"Diaphragmatic breathing reduces belching and proton pump inhibitor refractory gastroesophageal reflux symptoms","volume":"16","author":"Ong","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2018.09.001_bib0180","doi-asserted-by":"crossref","first-page":"8246171","DOI":"10.1155\/2016\/8246171","article-title":"Effects of transcutaneous electrical acustimulation on refractory gastroesophageal reflux disease","volume":"2016","author":"Meng","year":"2016","journal-title":"Evid Based Complement Alternat Med"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489218300456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489218300456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:50:13Z","timestamp":1761461413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489218300456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":36,"alternative-id":["S1471489218300456"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2018.09.001","relation":{},"ISSN":["1471-4892"],"issn-type":[{"type":"print","value":"1471-4892"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refractory GERD, beyond proton pump inhibitors","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2018.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}